Unsuccessful short-selling has reportedly put billionaire Carl Icahn's private hedge fund into a six-year-long red streak.

One insider scooped up many shares as Carl Icahn exited his stake in a medical device maker. There were other notable insider ...

Billionaire activist investor Carl Icahn exited stakes in Dana Inc. (NYSE:DAN) and Illumina (NASDAQ:ILMN) in Q2, according to ...

The Trump administration is casting a wide net, scouring other companies that it thinks could be ripe for some form of ...

Contact lens maker Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the ...

Carl Icahn disclosed in a regulatory filing no position in Bausch Health (BHC). Icahn has sold his firm’s entire position in Bausch Health.Elevate Your Investing Strategy: Take advantage of TipRanks ...

The president is demanding government stakes in U.S. companies and cuts of their revenue. Experts see some similarities to ...

President Trump's government stakes in US companies raise concerns about a shift towards state-managed capitalism, alarming ...

NASHVILLE, Tenn. (WKRN) — A scrapyard along the Cumberland River in downtown Nashville has officially been sold. The 45-acre ...

Icahn's reportable stock portfolio totaled nearly $28 billion in value as of September 30, 2015. Its top two holdings, Icahn Enterprises L.P. and Apple, made up 48% of the overall portfolio's value.